483 Fresenius Kabi Austria Gmbh Mar 2017

483 Fresenius Kabi Austria Gmbh Mar 2017

$119 - Not in Stock

FDA investigators audited the Fresenius Kabi Austria Gmbh - Linz, Austria facility and issued inspectional observations (via FDA 483) on 24 Mar 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Mar 2017
  • Location: Linz, Austria
  • FEI: 3002807014

Pre-Order Not Available